跳至主要内容
临床试验/NL-OMON49313
NL-OMON49313已完成不适用

Advanced Image Supported Left Ventricular Lead Placement in Cardiac Resynchronization Therapy (ADVISE-CRT II trial) - ADVISE-CRT II trial

niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • An indication for cardiac resynchronization therapy according to the current
  • international evidence based guidelines for CRT (the 2013 European Society of
  • Cardiology Guidelines for cardiac pacing and cardiac resynchronization therapy)
  • - Chronic heart failure;
  • - New York Heart Association functional class II, III, IV (ambulatory);
  • - QRS duration *120ms;
  • - Optimal pharmacological therapy;
  • - Left ventricular ejection fraction *35%;

排除标准

  • - Contraindications for implantation of a CRT device;
  • - Age <18 years or incapacitated adult;
  • - Pregnancy; if there is anamnestic doubt regarding postmenopausal state (<1
  • year since last menstruation), a urine hCG test (Alere) will be performed.
  • - Subjects with impaired renal function (severe renal insufficiency, GFR < 30
  • ml/min/1.73m2);
  • - Atrial fibrillation or atrial fibrillation during MRI
  • - Lactation;
  • - Documented allergic reaction to gadolinium;
  • - Documented allergic reaction to contrast agent;
  • - Impossibility to undergo a MRI scan (determined by using the standard
  • contraindications for MR imaging as used for clinical purposes).
  • - Participation in another clinical study that prohibits or influences any
  • procedures other than standard.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验